GlassScriptPhysician profile
Petra Glover
NPI 1730615790
$3,358.19
in general payments reported to CMS, 2019-2025
29 companies · $710 in 2025
The $710 reported for 2025 was more than what 79% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $543 · 2022: $370 · 2023: $958 · 2024: $776 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,444.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $400.85 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $394.90 | 2022-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $387.28 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $292.85 | 2021-2025 | Farxiga, Andexxa |
| Abbott Laboratories | $181.91 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Pfizer INC. | $176.93 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $172.61 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.75 | 2022-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $160.02 | 2021-2025 | Lifevest |
| Novo Nordisk INC | $145.97 | 2021-2025 | Rybelsus, Ozempic |
| Atricure, INC. | $125.82 | 2023 | |
| Boston Scientific Corporation | $123.42 | 2025 | Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $119.76 | 2021-2025 | |
| Cvrx, INC. | $99.37 | 2023-2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $87.56 | 2021-2023 | Xarelto |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $68.44 | 2021-2023 | Nexletol |
| Baxter Healthcare | $41.04 | 2024 | Hillrom - Eli280 Cardiograph |
| Alnylam Pharmaceuticals INC. | $31.07 | 2021-2023 | Onpattro |
| Vital Connect, INC | $27.22 | 2024 | Vitalpatch Rtm |
| Lantheus Medical Imaging, INC. | $20.13 | 2021 | |
| Shockwave Medical, INC | $17.80 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lexicon Pharmaceuticals, INC. | $16.64 | 2023 | Inpefa |
| Sanofi-Aventis U.S. LLC | $15.93 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $15.56 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $15.39 | 2024 | |
| Philips North America LLC | $15.31 | 2022 | |
| Irhythm Technologies, INC. | $14.62 | 2023 | Zio Xt Patch |
| Lemaitre Vascular, INC. | $14.12 | 2022 | |
| Medtronic, INC. | $13.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Petra Glover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.